{
  "original_data": {
    "question": "A 58-year-old male presents with an acutely elevated blood pressure of 220/140 mmHg. The patient complains of a headache and chest pain, and he has been vomiting for the last several hours. Physical exam demonstrates papilledema and a depressed level of consciousness. To treat this patient's hypertensive emergency, he is started on an IV medication commonly used in this situation. The agent exerts its effect by releasing nitric oxide as a metabolite, which subsequently activates guanylate cyclase and increases production of cGMP in vascular smooth muscle. Which of the following clinical effects would be expected from administration of this medication?",
    "options": {
      "A": "Decreased cardiac contractility",
      "B": "Increased left ventricular end-diastolic pressure",
      "C": "Decreased stroke volume",
      "D": "Decreased pulmonary capillary wedge pressure"
    }
  },
  "model_response": "This patient's presentation is consistent with a hypertensive emergency, which requires immediate reduction of blood pressure to prevent complications such as hypertensive encephalopathy, stroke, or myocardial ischemia. The most common medications used to treat hypertensive emergencies are nitroprusside, nicardipine, or clevidipine. Nitroprusside is a potent arterial and venous vasodilator that releases nitric oxide (NO) to activate guanylate cyclase and increase cyclic guanosine monophosphate (cGMP) levels in smooth muscle. This leads to smooth muscle relaxation, decreased systemic vascular resistance, and decreased blood pressure. The increased production of cGMP within the smooth muscle of the vasculature leads to venodilation and decreased preload, which subsequently leads to decreased left ventricular end-diastolic pressure (B). Nicardipine and clevidipine also decrease blood pressure by decreasing systemic vascular resistance, but they do so by directly acting on the smooth muscle and not through the production of NO. Therefore, these medications do not increase cGMP levels. Decreased cGMP levels would lead to increased systemic vascular resistance and increased blood pressure. Decreased cardiac contractility (A) would lead to decreased stroke volume.\n\n###Answer: OPTION B IS CORRECT.</s><s>",
  "question_entities": [
    {
      "text": "male",
      "type": "T032",
      "umls_id": "C0086582",
      "score": 0.9951750040054321,
      "semantic_types": [
        "T032"
      ],
      "definition": "A person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both."
    },
    {
      "text": "elevated",
      "type": "T080",
      "umls_id": "C0205250",
      "score": 0.9777681231498718,
      "semantic_types": [
        "T080"
      ],
      "definition": "An elevated level or position or degree; greater than normal in degree or intensity or amount."
    },
    {
      "text": "blood pressure",
      "type": "T040",
      "umls_id": "C0005823",
      "score": 0.9879373908042908,
      "semantic_types": [
        "T040"
      ],
      "definition": "PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS."
    },
    {
      "text": "mmHg",
      "type": "T081",
      "umls_id": "C0439475",
      "score": 0.989119827747345,
      "semantic_types": [
        "T081"
      ],
      "definition": "A non-SI unit of pressure equal to 133,332 Pa or 1.316E10-3 standard atmosphere. Use of this unit is generally deprecated by ISO and IUPAC."
    },
    {
      "text": "patient complains",
      "type": "UNKNOWN"
    },
    {
      "text": "headache",
      "type": "T184",
      "umls_id": "C0018681",
      "score": 0.9900735020637512,
      "semantic_types": [
        "T184"
      ],
      "definition": "The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS."
    },
    {
      "text": "chest pain",
      "type": "T184",
      "umls_id": "C0008031",
      "score": 0.9849169850349426,
      "semantic_types": [
        "T184"
      ],
      "definition": "Pressure, burning, or numbness in the chest."
    },
    {
      "text": "vomiting",
      "type": "T184",
      "umls_id": "C0042963",
      "score": 0.9573907256126404,
      "semantic_types": [
        "T184"
      ],
      "definition": "The forcible expulsion of the contents of the STOMACH through the MOUTH."
    },
    {
      "text": "Physical exam",
      "type": "T058",
      "umls_id": "C0031809",
      "score": 0.9741718769073486,
      "semantic_types": [
        "T058"
      ],
      "definition": "Systematic and thorough inspection of the patient for physical signs of disease or abnormality."
    },
    {
      "text": "papilledema",
      "type": "T047",
      "umls_id": "C0030353",
      "score": 0.9847666621208191,
      "semantic_types": [
        "T047"
      ],
      "definition": "Swelling of the OPTIC DISK, usually in association with increased intracranial pressure, characterized by hyperemia, blurring of the disk margins, microhemorrhages, blind spot enlargement, and engorgement of retinal veins. Chronic papilledema may cause OPTIC ATROPHY and visual loss. (Miller et al., Clinical Neuro-Ophthalmology, 4th ed, p175)"
    },
    {
      "text": "depressed level",
      "type": "T048",
      "umls_id": "C0344315",
      "score": 0.7861524224281311,
      "semantic_types": [
        "T048"
      ],
      "definition": "An emotional state characterized by feelings of sadness, emptiness, and/or tearfulness."
    },
    {
      "text": "consciousness",
      "type": "T033",
      "umls_id": "C0009791",
      "score": 0.9636605381965637,
      "semantic_types": [
        "T033"
      ],
      "definition": null
    },
    {
      "text": "patient's",
      "type": "T078",
      "umls_id": "C0030706",
      "score": 0.8150922656059265,
      "semantic_types": [
        "T078"
      ],
      "definition": "Fundamental claims of patients, as expressed in statutes, declarations, or generally accepted moral principles. (Bioethics Thesaurus) The term is used for discussions of patient rights as a group of many rights, as in a hospital's posting of a list of patient rights."
    },
    {
      "text": "hypertensive emergency",
      "type": "T047",
      "umls_id": "C0745136",
      "score": 0.9894223213195801,
      "semantic_types": [
        "T047"
      ],
      "definition": null
    },
    {
      "text": "IV medication",
      "type": "T121",
      "umls_id": "C1971835",
      "score": 0.9551301598548889,
      "semantic_types": [
        "T121"
      ],
      "definition": null
    },
    {
      "text": "agent",
      "type": "T120",
      "umls_id": "C0450442",
      "score": 0.9800482988357544,
      "semantic_types": [
        "T120"
      ],
      "definition": "An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect."
    },
    {
      "text": "effect",
      "type": "T080",
      "umls_id": "C1280500",
      "score": 0.9828534126281738,
      "semantic_types": [
        "T080"
      ],
      "definition": "A phenomenon that follows and is caused by some previous phenomenon."
    },
    {
      "text": "releasing nitric oxide",
      "type": "T121",
      "umls_id": "C0028128",
      "score": 0.7304657101631165,
      "semantic_types": [
        "T121",
        "T197"
      ],
      "definition": "A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP."
    },
    {
      "text": "metabolite",
      "type": "T123",
      "umls_id": "C0870883",
      "score": 0.9883963465690613,
      "semantic_types": [
        "T123"
      ],
      "definition": "Any substance involved in metabolism, either as a product of metabolism or as necessary for metabolism."
    },
    {
      "text": "guanylate cyclase",
      "type": "T116",
      "umls_id": "C0018358",
      "score": 0.9834542870521545,
      "semantic_types": [
        "T116",
        "T126"
      ],
      "definition": "An enzyme that catalyzes the conversion of GTP to 3',5'-cyclic GMP and pyrophosphate. It also acts on ITP and dGTP. (From Enzyme Nomenclature, 1992) EC 4.6.1.2."
    },
    {
      "text": "increases",
      "type": "T081",
      "umls_id": "C0205217",
      "score": 0.9777454733848572,
      "semantic_types": [
        "T081"
      ],
      "definition": null
    },
    {
      "text": "production",
      "type": "T057",
      "umls_id": "C0033268",
      "score": 0.9784734845161438,
      "semantic_types": [
        "T057"
      ],
      "definition": "The creation of goods and services by a manufacturing process."
    },
    {
      "text": "cGMP",
      "type": "T114",
      "umls_id": "C0018338",
      "score": 0.9899820685386658,
      "semantic_types": [
        "T114",
        "T123"
      ],
      "definition": "Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed)"
    },
    {
      "text": "vascular smooth muscle",
      "type": "T024",
      "umls_id": "C0026844",
      "score": 0.9840959906578064,
      "semantic_types": [
        "T024"
      ],
      "definition": "The nonstriated involuntary muscle tissue of blood vessels."
    },
    {
      "text": "clinical effects",
      "type": "T080",
      "umls_id": "C0205210",
      "score": 0.7142130136489868,
      "semantic_types": [
        "T080"
      ],
      "definition": "Relating to the examination and treatment of patients dependent on direct observation. The term may also refer to the institution (clinic) providing this activity."
    },
    {
      "text": "administration",
      "type": "T057",
      "umls_id": "C0001554",
      "score": 0.9601402878761292,
      "semantic_types": [
        "T057"
      ],
      "definition": "Performing or possessing executive duties; acting as a supervisor or manager."
    },
    {
      "text": "medication",
      "type": "T121",
      "umls_id": "C0013227",
      "score": 0.9858695864677429,
      "semantic_types": [
        "T121"
      ],
      "definition": "Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form."
    },
    {
      "text": "58-year-old",
      "type": "AGE_VALUE",
      "umls_id": null,
      "score": null,
      "semantic_types": null,
      "definition": null
    }
  ]
}